Welcome to the Empowered Patient Podcast with Karen Jagoda. This show is a window into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the changing dynamics in the medical and healthcare environment. One focus is on how providers, pharmaceutical companies, and payers are empowering patients. In addition, conversations are often about how providers, care facilities, pharmaceutical companies, and payers are being empowered by technology to improve patient outcomes and reduce friction across the healthcare landscape.
Popular Topics
- Virtual and digital health
- Use of AI, ML, and LLM in healthcare and drug discovery, development, trials
- Value-based healthcare
- Precision and stratified medicine
- Integration of digital technology into existing workflow and procedures
- Next-generation immuno, cell, and gene therapies
- Vaccines
- Biomarkers, sequencing, and imaging
- Rare diseases
- MedTech and medical devices
- Clinical trials
- Addressing Social Determinants of Health
- Treating chronic conditions like obesity and pain
- Clinician and staff burnout
The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.
Check out our new EmpoweredPatient.Solutions site where you can quickly search all of the Empowered Patient Podcast interviews by any word or phrase to identify useful resources, potential partners, and insights about the life sciences landscape.
Developing Psychedelic Therapy for Rapid Improvement of Postpartum Depression with Greg Mayes Reunion Neuroscience TRANSCRIPT
Download PDFDec 17, 2024
Greg Mayes, President and CEO of Reunion Neuroscience, is developing a psychedelic therapy for the treatment of postpartum depression. This serious acute, non-chronic mental health condition affects an estimated 20% of women after giving birth. A phase two trial is underway to evaluate how RE-104, a rapid-acting...
Dec 17, 2024
Greg Mayes, President and CEO of Reunion Neuroscience, is developing a psychedelic therapy for the treatment of postpartum depression. This serious acute, non-chronic mental health condition affects an estimated 20% of women after giving birth. A phase two trial is underway to evaluate how RE-104, a rapid-acting...
Precision Psychiatry Approach Using Neurotyping to Treat Depression with Dr. Kazu Okuda Universal Brain TRANSCRIPT
Download PDFApr 23, 2024
Dr. Kazu Okuda, Founder, and CEO of Universal Brain, uses neurotyping based on EEG data to better understand the different types of depression and deliver more precise treatments. To facilitate the availability of EEG data, Universal Brain has developed a next-generation EEG headset that is affordable and comfortable....
Apr 23, 2024
Dr. Kazu Okuda, Founder, and CEO of Universal Brain, uses neurotyping based on EEG data to better understand the different types of depression and deliver more precise treatments. To facilitate the availability of EEG data, Universal Brain has developed a next-generation EEG headset that is affordable and comfortable....
Advocating for Mainstreaming Psychedelic Therapies to Treat Mental Health Conditions with Dr. Steve Xenakis American Psychedelic Practitioners Association TRANSCRIPT
Download PDFDec 19, 2023
Retired Brigadier General Dr. Steve Xenakis is Executive Director of the American Psychedelic Practitioners Association, a group of clinicians who are interested in developing and promoting the mainstream use of psychedelic and plant medicines for the treatment of mental health conditions. APPA works to...